296 related articles for article (PubMed ID: 27135245)
1. Subclinical Hypothyroidism after 131I-Treatment of Graves' Disease: A Risk Factor for Depression?
Yu J; Tian AJ; Yuan X; Cheng XX
PLoS One; 2016; 11(5):e0154846. PubMed ID: 27135245
[TBL] [Abstract][Full Text] [Related]
2. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease.
Uy HL; Reasner CA; Samuels MH
Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422
[TBL] [Abstract][Full Text] [Related]
3. Natural history of mild subclinical hypothyroidism: prognostic value of ultrasound.
Rosário PW; Bessa B; Valadão MM; Purisch S
Thyroid; 2009 Jan; 19(1):9-12. PubMed ID: 19021461
[TBL] [Abstract][Full Text] [Related]
4. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
5. Subclinical Hypothyroidism with Negative for Thyroid Peroxidase Antibodies in Pregnancy: Intellectual Development of Offspring.
Chen J; Zhu J; Huang X; Zhao S; Xiang H; Zhou P; Zhou T; Xu Z
Thyroid; 2022 Apr; 32(4):449-458. PubMed ID: 34915770
[No Abstract] [Full Text] [Related]
6. Relapse of Graves' disease 23 years after treatment with radioactive iodine (131I).
Hegele RA; Volpé R
J Clin Lab Immunol; 1985 Oct; 18(2):103-5. PubMed ID: 3841162
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin receptor antibodies and Graves' disease, a side-effect of 131I treatment in patients with nontoxic goiter.
Nygaard B; Knudsen JH; Hegedüs L; Scient AV; Hansen JE
J Clin Endocrinol Metab; 1997 Sep; 82(9):2926-30. PubMed ID: 9284721
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of radioiodine (131I) therapy in 331 patients with Graves' disease.
Saito S; Sakurada T; Yamamoto M; Yoshida K; Kaise K; Kaise N; Yoshinaga K
Tohoku J Exp Med; 1980 Sep; 132(1):1-10. PubMed ID: 6894205
[TBL] [Abstract][Full Text] [Related]
9. Influence of high tissue-absorbed dose on anti-thyroid antibodies in radioiodine therapy of Graves' disease patients.
Listewnik MH; Piwowarska-Bilska H; Jasiakiewicz K; Birkenfeld B
Adv Clin Exp Med; 2021 Sep; 30(9):913-921. PubMed ID: 34418335
[TBL] [Abstract][Full Text] [Related]
10. Postradioiodine Graves' management: The PRAGMA study.
Perros P; Basu A; Boelaert K; Dayan C; Vaidya B; Williams GR; Lazarus JH; Hickey J; Drake WM; Crown A; Orme SM; Johnson A; Ray DW; Leese GP; Jones TH; Abraham P; Grossman A; Rees A; Razvi S; Gibb FW; Moran C; Madathil A; Žarković MP; Plummer Z; Jarvis S; Falinska A; Velusamy A; Sanderson V; Pariani N; Atkin SL; Syed AA; Sathyapalan T; Nag S; Gilbert J; Gleeson H; Levy MJ; Johnston C; Sturrock N; Bennett S; Mishra B; Malik I; Karavitaki N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):664-675. PubMed ID: 35274331
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of thyroid autoimmunity and effect of levothyroxine treatment in a cohort of 1064 patients with recurrent pregnancy loss.
Leduc-Robert G; Iews M; Abdelkareem AO; Williams C; Bloomenthal D; Abdelhafez F; Bedaiwy MA
Reprod Biomed Online; 2020 Apr; 40(4):582-592. PubMed ID: 32160949
[TBL] [Abstract][Full Text] [Related]
12. Role of thyroid-stimulating blocking antibody in patients who developed hypothyroidism within one year after 131I treatment for Graves' disease.
Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Nakazato N; Tani J; Abe K
Clin Endocrinol (Oxf); 1998 Jan; 48(1):17-22. PubMed ID: 9509063
[TBL] [Abstract][Full Text] [Related]
13. Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.
Chiovato L; Fiore E; Vitti P; Rocchi R; Rago T; Dokic D; Latrofa F; Mammoli C; Lippi F; Ceccarelli C; Pinchera A
J Clin Endocrinol Metab; 1998 Jan; 83(1):40-6. PubMed ID: 9435414
[TBL] [Abstract][Full Text] [Related]
14. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
16. NIS mRNA expression level in resected thyroid tissue as a marker of postoperative hypothyroidism after subtotal thyroidectomy in patients with Graves' disease.
Goto A; Uchino S; Noguchi S; Wakiya S; Watanabe Y; Murakami T; Matsuura B; Onji M
Endocr J; 2008 Mar; 55(1):73-81. PubMed ID: 18187871
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids do not influence the effect of radioiodine therapy in Graves' disease.
Jensen BE; Bonnema SJ; Hegedüs L
Eur J Endocrinol; 2005 Jul; 153(1):15-21. PubMed ID: 15994741
[TBL] [Abstract][Full Text] [Related]
18. Transient hypothyroidism after iodine-131 treatment of Graves' disease.
Gómez JM; Virgili N; Soler J; Fernández M; Montaña E
Thyroidology; 1989 Dec; 1(3):149-52. PubMed ID: 2484879
[TBL] [Abstract][Full Text] [Related]
19. "Hypothyroidism screening during first trimester of pregnancy".
Castillo Lara M; Vilar Sánchez Á; Cañavate Solano C; Soto Pazos E; Iglesias Álvarez M; González Macías C; Ayala Ortega C; Moreno Corral LJ; Fernández Alba JJ
BMC Pregnancy Childbirth; 2017 Dec; 17(1):438. PubMed ID: 29273014
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
Wood LC; Ingbar SH
J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
